BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.91
-0.12 (-1.33%)
At close: Apr 2, 2026, 4:00 PM EDT
9.08
+0.17 (1.91%)
After-hours: Apr 2, 2026, 4:42 PM EDT

BBOT Stock Forecast

Stock Price Forecast

The 7 analysts that cover BBOT stock have a consensus rating of "Strong Buy" and an average price target of $24, which forecasts a 169.36% increase in the stock price over the next year. The lowest target is $20 and the highest is $29.

Price Target: $24 (+169.36%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$20$24$24$29
Change+124.47%+169.36%+169.36%+225.48%
* Price targets were last updated on Mar 6, 2026.

Analyst Ratings

The average analyst rating for BBOT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy111222
Buy345555
Hold000000
Sell000000
Strong Sell000000
Total456777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$27$29
Strong BuyMaintains$27$29+225.48%Mar 6, 2026
Stifel
Stifel
Strong Buy
Initiates
$23
Strong BuyInitiates$23+158.14%Feb 11, 2026
Raymond James
Raymond James
Buy
Initiates
$24
BuyInitiates$24+169.36%Jan 9, 2026
Wedbush
Wedbush
Buy
Reiterates
$25
BuyReiterates$25+180.58%Dec 11, 2025
Morgan Stanley
Morgan Stanley
Buy
Initiates
$20
BuyInitiates$20+124.47%Dec 5, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.35
from -4.30
EPS Next Year
-2.69
from -2.35
Fiscal YearFY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
------
Revenue Growth
------
EPS
-518.73-5,756.41-4.30-2.35-2.69-
EPS Growth
------
Forward PE
------
No. Analysts
---111010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202620272028
High--
Avg--
Low--

EPS Forecast

EPS20262027
High-2.14-1.94
Avg-2.35-2.69
Low-2.52-3.28

EPS Growth

EPS Growth20262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.